Skip to main content

Eurostars — Portfolio

Investor actively backing innovative startups and growth-stage companies across various industries and funding rounds.

68
Companies
$171.7M
Total invested
$3.4M
Avg. check
39
Industries
Biotechnology 13Health Care 8Pharmaceutical 6Life Science 5Software 4Therapeutics 3+33 more
Founder contacts

Verified emails & LinkedIn for founders across this portfolio.

jane@on●●●●●●●.com
linkedin.com/in/●●●●●●
Verified contacts, updated monthly
Get instant access →

Portfolio companies

Showing 124 of 68
ProVascTec
September 2025

ProVascTec is a preclinical stage cell treatment firm, to stimulate the development of a novel circulatory system.

Biotechnology · Cork$2.9M Grant
INERGIO
September 2025

INERGIO is a reliable power power supply yet is a challenge to off-grid systems.

Environmental Consulting · LausanneGrant
Nanomik Biotechnology
August 2025

Developing patented biodegradable microencapsulation technology delivering biological protection across industries.

AgTech · Istanbul$1.5M Grant
Vandria
August 2024

Vandria creates mitophagy inducers that renew cells to address ageing and chronic disorders.

Manufacturing · Lausanne$10.1M Series A
ExoLabs
August 2021

ExoLabs provides tailored software solutions and data products.

Cloud Data Services · Zürich$1.9M Grant
Brenus Pharma
July 2026

Brenus Pharma is an allogeneic platform to generate immune therapy ambitioning to harness patient immune system & prevent cancer resistance.

Biotechnology · Issoire$12.6M Series A
Gain Therapeutics
July 2025

Gain Therapeutics is a biotech company developing pharmacological chaperones drugs designed to treat rare metabolic disorders.

Biotechnology · Bethesda$7.0M Post-IPO Equity
LenioBio
July 2025

LenioBio develops rapid plant-based, cell-free protein expression that scales for research, development and production.

Biotechnology · Düsseldorf$4.4M Grant
my mhealth
June 2022

my mhealth developed a web-based COPD self-management programme.

Health Care · Bournemouth$624K Grant
AlveoliX AG
June 2026

AlveoliX provides in-vitro solutions based on proprietary and unique organ-on-chip technologies.

Biotechnology · Berne$1.2M Grant
Smart Reporting
April 2024

Smart Reporting is a digital health start-up that provides documentation software in the medical field.

Health Care · Munich$24.5M Series C
Terapet
April 2026

Geneva-based MedTech spin-off from CERN, specializing in the development and manufacturing of innovative nuclear imaging systems.

Health Care · Geneva$2.6M Grant
NOVIGENIX
March 2025

Novigenix is a precision medicine company that specializes in ImmunoTranscriptomic solutions.

Artificial Intelligence (AI) · Epalinges$1.9M Grant
Cellevate
March 2026

Cellevate is an innovative biotech company that develops the next generation of cell culture systems.

Biotechnology · Lund$2.2M Seed
Polar Light Technologies
March 2026

Polar Light Technologies focuses on developing the next generation of Nano and micro LED technology.

Lighting · LinköpingGrant
LipUm
March 2026

LipUm operates as a biotechnology company that offers anti-inflammatory drugs.

Biotechnology · Umeå$9.3M Grant
bNovate Technologies
February 2025

BNovate Technologies develops automated water monitoring solutions, specializing in microbiological analysis through flow cytometry.

Biotechnology · Ecublens$4.2M Grant
NEOGAP Therapeutics
February 2026

NEOGAP Therapeutics is a Pharmaceutical manufacturing industry.

Biotechnology · Stockholm$9.8M Venture - Series Unknown
Perciv AI
December 2024

Perciv offers AI based software solutions to unleash the hidden capabilities of radars and enable robust autonomous systems.

Artificial Intelligence (AI) · Delft$2.6M Seed
PhysioMRI
September 2023

PhysioMRI is a manufacturer of MRI machines and medical devices.

Manufacturing · Valencia$4.3M Seed
Hylomorph
September 2023

Hylomorph is a MedTech company that specializes in providing fibrotic encapsulation solutions in implantable medical devices.

Health Care · Zurich$5.1M Series B
Chouette
February 2023

Chouette is an innovative start-up that specializes in the analysis of vines.

Agriculture · Paris$4.8M Venture - Series Unknown
ToxGenSolutions
January 2023

(Epi-)genetics for preclinical diagnostics and preventative therapeutics for high-impact chronic neurodegenerative and rare pathologies

Biotechnology · Maastricht$263K Grant
Mycorena
January 2023

Mycorena is a fungi-based, next-generation vegan protein and food manufacturing solution to plants, using significantly less resources.

Biotechnology · GothenburgGrant

Where Eurostars invests

Biotechnology13
Health Care8
Pharmaceutical6
Life Science5
Software4
Therapeutics3

About Eurostars's portfolio

How many companies has Eurostars invested in?

Eurostars has invested in 68 companies tracked in our database. The portfolio spans multiple industries and funding stages, from seed-stage startups to late-stage companies.

What industries does Eurostars invest in?

Eurostars's top investment sectors include Biotechnology, Health Care, Pharmaceutical, Life Science, Software. The firm invests across 39 different industry categories.

What is Eurostars's largest investment?

Among tracked funding rounds, Smart Reporting received $24.5M in a Series C round. Eurostars's total known invested capital is $171.7M.

What is the average investment size for Eurostars?

Eurostars's average investment size is $3.4M across its portfolio of 68 companies.

What are Eurostars's most recent investments?

Recent Eurostars portfolio additions include ProVascTec, INERGIO, Nanomik Biotechnology, Vandria, ExoLabs. These companies were founded in 2020 or later.

Reach the founders behind these 68 companies
Verified emails and LinkedIn profiles, updated monthly.
Get instant access →